Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12350334 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, Carl H. June | 2025-07-08 |
| 12234274 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Carl H. June, Avery D. Posey | 2025-02-25 |
| 11958892 | Use of ICOS-based cars to enhance antitumor activity and car persistence | Carl H. June, Sonia Guedan Carrio, Yangbing Zhao | 2024-04-16 |
| 11865167 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Carl H. June, Andreas Loew, Marcela Maus +1 more | 2024-01-09 |
| 11718685 | Compositions and methods for targeting stromal cells for the treatment of cancer | Carl H. June, Ellen Puré, Liang-Chuan Wang, Steven M. Albelda | 2023-08-08 |
| 11597754 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Carl H. June, Avery D. Posey | 2023-03-07 |
| 11299536 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, Carl H. June | 2022-04-12 |
| 11028177 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Jennifer Brogdon, Saar Gill, Carl H. June, Michael D. Kalos, Andreas Loew | 2021-06-08 |
| 10927184 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Carl H. June, Andreas Loew, Marcela Maus | 2021-02-23 |
| 10800840 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, Carl H. June | 2020-10-13 |
| 10577407 | Use of ICOS-based CARS to enhance antitumor activity and CAR persistence | Carl H. June, Sonia Guedan Carrio, Yangbing Zhao | 2020-03-03 |
| 10501519 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Carl H. June, Avery D. Posey | 2019-12-10 |
| 10329355 | Compositions and methods for targeting stromal cells for the treatment of cancer | Carl H. June, Ellen Puré, Liang-Chuan Wang, Steven M. Albelda | 2019-06-25 |
| 10308717 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Carl H. June, Andreas Loew, Marcela Maus +1 more | 2019-06-04 |
| 10221245 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Carl H. June, Andreas Loew, Marcela Maus | 2019-03-05 |
| 10040846 | Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer | Matthew J. Frigault, Yangbing Zhao, Carl H. June | 2018-08-07 |
| 9783591 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Carl H. June, Avery D. Posey | 2017-10-10 |
| 9714278 | Use of ICOS-based CARs to enhance antitumor activity and CAR persistence | Carl H. June, Sonia Guedan Carrio, Yangbing Zhao | 2017-07-25 |
| 9573988 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Jennifer Brogdon, Saar Gill, Carl H. June, Michael D. Kalos, Andreas Loew | 2017-02-21 |
| 9394368 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Carl H. June, Andreas Loew, Marcela Maus +1 more | 2016-07-19 |
| 9365641 | Compositions and methods for targeting stromal cells for the treatment of cancer | Carl H. June, Ellen Puré, Liang-Chuan Wang, Steven M. Albelda | 2016-06-14 |
| 6565856 | Compounds and methods for treatment and diagnosis of chlamydial infection | Yasir Skeiky | 2003-05-20 |